Statin Choice Decision Aid Implementation First Phase
NCT02375815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 313
Last updated 2017-03-24
Summary
This study is designed to answer a key question in the field of implementation science. Specifically, it seeks to determine if a proposed model for the implementation and scale-up of healthcare innovations (the AIDED model) is effective and useful. To fully evaluate the potential of this model, the investigators will conduct a multi-year study comprising 3 phases. This proposal represents the first of these phases.
Conditions
- Cardiovascular Factor Risk
Interventions
- OTHER
-
Statin Choice Implementation
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Victor Montori, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-03-31
Countries
- United States
Study Locations
More Related Trials
-
Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
NCT00723723 ·Status: COMPLETED
-
Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )
NCT00408057 ·Status: COMPLETED
-
Statins at the Primary Care Level
NCT02380911 ·Status: COMPLETED ·Phase: NA
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536796 ·Status: COMPLETED
-
Functional and Clinical Impact of CYP3A Genetic Polymorphisms on Statin Therapy
NCT01867203 ·Status: WITHDRAWN
-
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
NCT00557778 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance
NCT01751984 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3015014 in Participants With High Cholesterol
NCT01890967 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects
NCT01720537 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
NCT05614765 ·Status: ACTIVE_NOT_RECRUITING
-
Self-Assessment Method for Statin Side-effects Or Nocebo
NCT02668016 ·Status: COMPLETED ·Phase: PHASE4
-
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
NCT00158899 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
NCT00673660 ·Status: COMPLETED
-
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
NCT05889156 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Autonomy and Statin Therapy Adherence
NCT05845580 ·Status: COMPLETED ·Phase: NA
-
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
NCT02023879 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in People With High Cholesterol
NCT00133380 ·Status: COMPLETED ·Phase: PHASE2
-
Compliance With Treatment For Patients With Hyperlipidemia
NCT00828945 ·Status: COMPLETED
-
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
NCT01078285 ·Status: COMPLETED
-
Statin Therapy Results in the Real World Practice in the Czech Republic
NCT01055977 ·Status: COMPLETED
-
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
NCT03610321 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Statins for the Treatment of NASH
NCT04679376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of LY3015014 in Healthy Participants With High Cholesterol
NCT01671085 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
NCT01859455 ·Status: COMPLETED ·Phase: PHASE1
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536965 ·Status: COMPLETED